Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TYR | P14679 | 6/20 | 0.52 |
| ▸ | CETP | P11597 | 1/20 | 0.47 |
| ▸ | TLR4 | O00206 | 1/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.46 |
| ▸ | THRB | P10828 | 1/20 | 0.46 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.44 |
| ▸ | SELL | P14151 | 3/20 | 0.44 |
| ▸ | SELP | P16109 | 3/20 | 0.44 |
| ▸ | SELE | P16581 | 3/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13372925 | 1.00 | TYR (0.52) | TYRCETPTLR4ALDH1A1THRB | |
| SCHEMBL7591028 | 1.00 | TYR (0.52) | TYRCETPTLR4ALDH1A1THRB | |
| SCHEMBL1062211 | 1.00 | TYR (0.52) | TYRCETPTLR4ALDH1A1THRB | |
| SCHEMBL7205835 | 1.00 | TYR (0.52) | TYRCETPTLR4ALDH1A1THRB | |
| SCHEMBL13362516 | 1.00 | TYR (0.52) | TYRCETPTLR4ALDH1A1THRB | |
| SCHEMBL347694 | 1.00 | TYR (0.52) | TYRCETPTLR4ALDH1A1THRB | |
| SCHEMBL13372924 | 1.00 | TYR (0.52) | TYRCETPTLR4ALDH1A1THRB | |
| SCHEMBL13372944 | 1.00 | TYR (0.52) | TYRCETPTLR4ALDH1A1THRB | |
| SCHEMBL13372928 | 1.00 | TYR (0.52) | TYRCETPTLR4ALDH1A1THRB | |
| SCHEMBL2420891 | 1.00 | TYR (0.52) | TYRCETPTLR4ALDH1A1THRB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20020165168-A1 | USE OF SUGAR DERIVATIVES AS ANTIMICROBIAL, ANTIMYCOTIC AND/OR ANTIVIRAL ACTIVE SUBSTANCES | BEIERDORF AG (DE) | 2002-11-07 | — | — | US | claimed |
| US-20020165168-A1 | USE OF SUGAR DERIVATIVES AS ANTIMICROBIAL, ANTIMYCOTIC AND/OR ANTIVIRAL ACTIVE SUBSTANCES | BEIERDORF AG (DE) | 2002-11-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020165168-A1 | USE OF SUGAR DERIVATIVES AS ANTIMICROBIAL, ANTIMYCOTIC AND/OR ANTIVIRAL ACTIVE SUBSTANCES | TREH, MGAM, FUT6 | TYR 1638/4885CETP 1128/4885TLR4 170/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.